These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line. Tao J; Shi L; Huang L; Shi H; Chen H; Wang Y; Wang T J Cancer Res Clin Oncol; 2017 Nov; 143(11):2211-2219. PubMed ID: 28748258 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of EZH2 inhibits epithelial-mesenchymal transition in enzalutamide-resistant prostate cancer. Zhang Z; Wang X; Kim M; He D; Wang C; Fong KW; Liu X Prostate; 2023 Nov; 83(15):1458-1469. PubMed ID: 37475584 [TBL] [Abstract][Full Text] [Related]
5. Loss of long noncoding RNA FOXF1-AS1 regulates epithelial-mesenchymal transition, stemness and metastasis of non-small cell lung cancer cells. Miao L; Huang Z; Zengli Z; Li H; Chen Q; Yao C; Cai H; Xiao Y; Xia H; Wang Y Oncotarget; 2016 Oct; 7(42):68339-68349. PubMed ID: 27577075 [TBL] [Abstract][Full Text] [Related]
6. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis. Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460 [TBL] [Abstract][Full Text] [Related]
9. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition. Sun M; Liu XH; Lu KH; Nie FQ; Xia R; Kong R; Yang JS; Xu TP; Liu YW; Zou YF; Lu BB; Yin R; Zhang EB; Xu L; De W; Wang ZX Cell Death Dis; 2014 Jun; 5(6):e1298. PubMed ID: 24967960 [TBL] [Abstract][Full Text] [Related]
11. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas. Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529 [TBL] [Abstract][Full Text] [Related]
12. Mutations and deletions of PRC2 in prostate cancer. Jain P; Di Croce L Bioessays; 2016 May; 38(5):446-54. PubMed ID: 27000413 [TBL] [Abstract][Full Text] [Related]
13. KDM2B is involved in the epigenetic regulation of TGF-β-induced epithelial-mesenchymal transition in lung and pancreatic cancer cell lines. Wanna-Udom S; Terashima M; Suphakhong K; Ishimura A; Takino T; Suzuki T J Biol Chem; 2021; 296():100213. PubMed ID: 33779563 [TBL] [Abstract][Full Text] [Related]
14. EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells. Zheng M; Cao MX; Luo XJ; Li L; Wang K; Wang SS; Wang HF; Tang YJ; Tang YL; Liang XH J Cell Mol Med; 2019 Oct; 23(10):6942-6954. PubMed ID: 31368152 [TBL] [Abstract][Full Text] [Related]
15. A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis. Li L; Liu J; Xue H; Li C; Liu Q; Zhou Y; Wang T; Wang H; Qian H; Wen T Oncogene; 2020 Mar; 39(10):2125-2139. PubMed ID: 31811272 [TBL] [Abstract][Full Text] [Related]
16. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2. Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878 [TBL] [Abstract][Full Text] [Related]
17. The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma. Matsubara T; Toyokawa G; Takada K; Kinoshita F; Kozuma Y; Akamine T; Shimokawa M; Haro A; Osoegawa A; Tagawa T; Mori M PLoS One; 2019; 14(5):e0215103. PubMed ID: 31042721 [TBL] [Abstract][Full Text] [Related]
18. SUMOylation of E2F1 Regulates Expression of EZH2. Du L; Fakih MG; Rosen ST; Chen Y Cancer Res; 2020 Oct; 80(19):4212-4223. PubMed ID: 32816857 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2. Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151 [TBL] [Abstract][Full Text] [Related]